• Citer

Dissecting the heterogeneity of triple-negative breast cancer.

par Metzger-Filho, Otto;Tutt, Andrew M;Azambuja, Evandro ;Saini, Kamal S;Viale, Giuseppe;Loi, Sherene ;Bradbury, Ian;Bliss, Judith M;Abdel Azim, Hatem Hamdy ;Ellis, Paul;Di Leo, Angelo ;Baselga, José;Sotiriou, Christos ;Piccart-Gebhart, Martine
Référence Journal of clinical oncology, 30, 15, page (1879-1887)
Publication Publié, 2012-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Dissecting the heterogeneity of triple-negative breast cancer.
Auteur:	Metzger-Filho, Otto; Tutt, Andrew M; Azambuja, Evandro; Saini, Kamal S; Viale, Giuseppe; Loi, Sherene; Bradbury, Ian; Bliss, Judith M; Abdel Azim, Hatem Hamdy; Ellis, Paul; Di Leo, Angelo; Baselga, José; Sotiriou, Christos; Piccart-Gebhart, Martine
Informations sur la publication:	Journal of clinical oncology, 30, 15, page (1879-1887)
Statut de publication:	Publié, 2012-05
Sujet CREF:	Cancérologie
MeSH keywords:	Antineoplastic Agents -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- chemistry -- classification -- epidemiology -- genetics -- pathology -- therapy
	Enzyme Inhibitors -- therapeutic use
	Female
	Gene Expression Profiling
	Gene Expression Regulation, Neoplastic
	Humans
	Molecular Targeted Therapy
	Poly(ADP-ribose) Polymerases -- antagonists & inhibitors
	Prognosis
	Receptor, erbB-2 -- analysis
	Receptors, Estrogen -- analysis
	Receptors, Progesterone -- analysis
	Tumor Markers, Biological -- analysis -- genetics
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	Review
	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2011.38.2010
	info:pii/JCO.2011.38.2010
	info:scp/84863994288
	info:pmid/22454417